POZ January-February 2022
POZ January-February 2022
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Feature
Inviting Death to Tea
Broadway Legend André De Shields on Life, Career, COVID-19 and HIV
How Well Do COVID Vaccines Work for People With HIV?
Overall, vaccines are highly effective, but some folks are at risk for poorer response.
History Reclaimed
Race, Queerness, Art and AIDS Resonate in the Work of Darrel Ellis.
2022 HIV/AIDS Awareness Days
Display this poster as a reminder of upcoming awareness days, and use the hashtags shown to promote them on social media.
Editor’s Letter
The Impossible Dream
For a few years, I seriously considered becoming a professional actor.
POZ Q+A
Kiki with an HIV Advocate
Maven Lee shares his HIV story while promoting balls, serving runway and starring on reality TV.
POZ Planet
Connect and Inspire Black Gay Men
THRIVE SS launches an app for same-gender-loving men of color, regardless of their HIV status.
When Lil Nas X Pays You a Visit
“He’s our Beyoncé!”
“We Need Your Donations!”
Aid for AIDS collects and distributes unused meds.
Everyday – January/February 2022
These dates represent milestones in the HIV epidemic.
Voices
The 340B Program
AIDS United’s working group of safety net providers weighs in on ending the epidemic.
More Than Words
NMAC executive director Paul Kawata pays homage to the late HIV activist Michael Hirsch, his friend and partner in crime.
Ask POZ
Ask POZ – January/February 2022
Who Should Receive Covid-19 Vaccine Boosters?
Basics
African Americans and HIV
Black communities are disproportionately affected by HIV and AIDS.
Research Notes
Prevention: PrEP Disparities
Disparities across states in pre-exposure prophylaxis (PrEP) use appear to have worsened over time.
Treatment: Biktarvy for Kids
Biktarvy is now available for small children.
Cure: Natural Cure
A second woman appears to have eliminated HIV naturally and may even be considered cured.
Concerns: Hep C Treatment
The number of people treated with direct-acting antiviral therapy for hepatitis C has steadily declined.
Care and Treatment
Lost in Translation: U=U
The news that an undetectable viral load prevents people from transmitting HIV through sex is getting lost in translation.
Race, Individual Behavior and Structural HIV Risk
Need more proof that individual behavior isn’t the only thing that determines whether you acquire HIV?
Early Treatment Reduces Anal Cancer Risk
Treating abnormal anal cell changes early can reduce the risk of progression to anal cancer in people living with HIV.
Cabenuva Works Regardless of Weight
Long-acting injectable Cabenuva works well in people with obesity.
Heroes
Proud Ally
Since August, Marlene McNeese has served as a member and cochair of PACHA.
Digital Edition
POZ January/February 2022
Read the digital edition!
